Innovation Pharmaceuticals Inc (IPIX)

[sox040713]

I think accelerated approval is more for cancer drugs (K-OC?), but B-OM does impact the way cancer drugs are being used. Why would Leo meet with members of Congress if accelerated approval isn’t possible and approval is at least two years away? Here’s an article from last week.

FDA aims to approve more drugs based on early clinical data

https://www.reuters.com/article/us-fda-hearing-testimony/fda-aims-to-approve-more-drugs-based-on-early-clinical-data-idUSKBN1DU2DS

Here’s a recent article on adaptive trial design, which could shorten the time of Phase 3 if needed.

Congress and FDA nominee heap love on ‘adaptive trials’

http://www.sciencemag.org/news/2017/04/congress-and-fda-nominee-heap-love-adaptive-trials